Danny Bar-Zohar

No­var­tis vet Dan­ny Bar-Zo­har leaps back in­to R&D, tak­ing over the de­vel­op­ment team at Mer­ck KGaA as Lu­ciano Ros­set­ti steps out

Af­ter a brief stint as a biotech in­vestor at Syn­cona, No­var­tis vet Dan­ny Bar-Zo­har is back in R&D, and he’s tak­ing the lead po­si­tion at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.